Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 156 articles:
HTML format



Single Articles


    June 2021
  1. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Hedberg J, et al
    Extent of Lymphadenectomy and Long-Term Survival in Esophageal Cancer.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93462.
    PubMed     Abstract available


  2. YANG Y, Li B, Yi J, Hua R, et al
    Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial.
    Ann Surg. 2021 Jun 18. pii: 00000658-900000000-93478.
    PubMed     Abstract available


  3. WANG BY, Lin CH, Wu SC, Chen HS, et al
    Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2021 Jun 10. pii: 00000658-900000000-93505.
    PubMed     Abstract available


  4. YANG W, Liu F, Xu R, Yang W, et al
    Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data.
    Ann Surg. 2021 Jun 2. pii: 00000658-900000000-93529.
    PubMed     Abstract available


    May 2021
  5. DU J, Shen X
    Comment on "Genomic Alteration and Immunity-Implications In Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93540.
    PubMed    


  6. DU J, Guan W, Shen X
    Comment on "Circulating Tumor Cells-New Indicator For Clinical Staging Of Patients With Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93536.
    PubMed    


  7. KOSUMI K, Baba Y, Baba H
    Response to Comment on "Genomic Alteration and Immunity-Implications in Esophageal Cancer".
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93548.
    PubMed    


  8. REEH M
    Response to Comment on "Circulating Tumor Cells - New Indicator for Clinical Staging of Patients with Esophageal Cancer" by Wenxian Guan.
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93547.
    PubMed    


  9. VAN DER WILK BJ, Eyck BM, Hofstetter WL, Ajani JA, et al
    Chemoradiotherapy followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis.
    Ann Surg. 2021 May 11. doi: 10.1097/SLA.0000000000004930.
    PubMed     Abstract available


  10. XIE SH, Santoni G, Malberg K, Lagergren P, et al
    Prediction Model of Long-term Survival After Esophageal Cancer Surgery.
    Ann Surg. 2021;273:933-939.
    PubMed     Abstract available


    April 2021
  11. HARADA K, Hwang H, Wang X, Abdelhakeem A, et al
    Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.
    Ann Surg. 2021;273:751-757.
    PubMed     Abstract available


  12. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a Simple Infective Complication? (ANNSURG-D21-00007).
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004873.
    PubMed    


  13. BABA Y, Kosumi K, Baba H
    Comments on "The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?"
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004879.
    PubMed    


    March 2021
  14. JAWITZ NG, Raman V, Jawitz OK, Shimpi RA, et al
    Utilization Trends and Volume-Outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer.
    Ann Surg. 2021 Mar 3. doi: 10.1097/SLA.0000000000004834.
    PubMed     Abstract available


  15. JOMRICH G, Paireder M, Kristo I, Baierl A, et al
    High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
    Ann Surg. 2021;273:532-541.
    PubMed     Abstract available


    February 2021
  16. GUO X, Wang Z, Yang H, Mao T, et al
    Impact of Lymph Node Dissection on Survival after Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93700.
    PubMed     Abstract available


    January 2021
  17. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Lindblad M, et al
    Long-term survival in esophageal cancer after minimally invasive esophagectomy compared to open esophagectomy.
    Ann Surg. 2021 Jan 20. pii: 00000658-900000000-93754.
    PubMed     Abstract available


  18. KUO JH, Lee JA
    The Adoption of Ultrasound-guided Radiofrequency Ablation of Thyroid Nodules in the United States.
    Ann Surg. 2021;273:e10-e12.
    PubMed    


    December 2020
  19. KALFF MC, Fransen LFC, de Groot EM, Gisbertz SS, et al
    Long-Term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-Score Matched Analysis.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  20. MAO QJ, Yan PJ, Liang YL
    Comment on "Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study".
    Ann Surg. 2020 Dec 3. doi: 10.1097/SLA.0000000000004158.
    PubMed    


    November 2020
  21. XUE FS, Xue ZJ, Wan L
    Comment on "Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004614.
    PubMed    


  22. MURPHY CF, Dunne T, Elliott JA, Kamarajah SK, et al
    Response to "Comment on Acute Kidney Injury after Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004609.
    PubMed    


  23. MAKINO T, Hagi T, Doki Y
    Response to Comment on: "Pathological Regression of Lymph Nodes Better Predicts Long-Term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004605.
    PubMed    


  24. CHEN D, Wen J, Zheng Y, Chen Y, et al
    Comment on "Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004606.
    PubMed    


  25. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004546.
    PubMed     Abstract available


  26. DONLON NE, Elliott JA, Donohoe CL, Murphy CF, et al
    Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype.
    Ann Surg. 2020;272:814-819.
    PubMed     Abstract available


  27. VOETEN DM, van der Werf LR, Wijnhoven BPL, van Hillegersberg R, et al
    Failure to Cure in Patients Undergoing Surgery for Esophageal Carcinoma: Hospital of Surgery Influences Prospects for Cure: A Nation-wide Cohort Study.
    Ann Surg. 2020;272:744-750.
    PubMed     Abstract available


    October 2020
  28. SHIN DW, Kim HK, Cho J, Lee G, et al
    Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004473.
    PubMed     Abstract available


  29. MATSUDA S, Kawakubo H, Okamura A, Takahashi K, et al
    Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2020 Oct 16. doi: 10.1097/SLA.0000000000004436.
    PubMed     Abstract available


  30. SUGIMURA K, Miyata H, Tanaka K, Makino T, et al
    Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin (DCF) Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients with Clinical T4b Esophageal Cancer: Short-t
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004564.
    PubMed     Abstract available


  31. CHEN H
    Follicular Neoplasms of the Thyroid: Can They Be Observed?
    Ann Surg. 2020;272:628.
    PubMed    


    September 2020
  32. YOSHIDA N, Eto K, Kurashige J, Izumi D, et al
    Comprehensive Analysis of Multiple Primary Cancers in Patients with Esophageal Squamous Cell Carcinoma Undergoing Esophagectomy.
    Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004490.
    PubMed     Abstract available


  33. SOSA JA
    When the World Around Changes While you are Doing Great Science.
    Ann Surg. 2020;272:504-505.
    PubMed    


  34. SIPPEL RS, Robbins SE, Poehls JL, Pitt SC, et al
    A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer.
    Ann Surg. 2020;272:496-503.
    PubMed     Abstract available


    August 2020
  35. VON HOLZEN U, Schmidt S, Hayoz S, Steffen T, et al
    Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08).
    Ann Surg. 2020 Aug 26. doi: 10.1097/SLA.0000000000004334.
    PubMed     Abstract available


  36. YASUDA T, Nishiki K, Hiraki Y, Kato H, et al
    Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects.
    Ann Surg. 2020 Aug 26. doi: 10.1097/SLA.0000000000003880.
    PubMed     Abstract available


  37. NILSSON K, Klevebro F, Rouvelas I, Lindblad M, et al
    Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004340.
    PubMed     Abstract available


  38. WONG IYH, Lam KO, Zhang RQ, Chan WWL, et al
    Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC): A Propensity Score-Matched Study.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004329.
    PubMed     Abstract available


  39. HARADA K, Wu CC, Wang X, Mizrak Kaya D, et al
    Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
    Ann Surg. 2020;272:311-318.
    PubMed     Abstract available


    July 2020
  40. MURPHY CF, Dunne T, Elliott JA, Kamarajah SK, et al
    Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004146.
    PubMed     Abstract available


  41. FAIZ Z, Kats-Ugurlu G, Mul VEM, Karrenbeld A, et al
    Locoregional Residual Esophageal Cancer after Neo-adjuvant Chemoradiotherapy and Surgery Regarding Anatomic Site and Radiation Target Fields: A Histopathologic Evaluation Study.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004242.
    PubMed     Abstract available


  42. HAGI T, Makino T, Yamasaki M, Yamashita K, et al
    Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery.
    Ann Surg. 2020 Jul 14. doi: 10.1097/SLA.0000000000004238.
    PubMed     Abstract available


  43. YOSHIDA N, Baba H
    Response to the Letter to the Editor for "Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study".
    Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004128.
    PubMed    


  44. CARTY SE, Ohori NP, Hilko DA, McCoy KL, et al
    The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules).
    Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004130.
    PubMed     Abstract available


  45. LENSCHOW C, Schragle S, Kircher S, Lorenz K, et al
    Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004144.
    PubMed     Abstract available


  46. YANO M, Sugimura K, Miyata H, Motoori M, et al
    Randomized Comparison of Gastric Tube Reconstruction With and Without Duodenal Diversion Plus Roux-en-Y Anastomosis After Esophagectomy.
    Ann Surg. 2020;272:48-54.
    PubMed     Abstract available


  47. NOBEL TB, Livschitz J, Eljalby M, Janjigian YY, et al
    Unique Considerations for Females Undergoing Esophagectomy.
    Ann Surg. 2020;272:113-117.
    PubMed     Abstract available


    June 2020
  48. VAN DER WERF LR, Busweiler LAD, van Sandick JW, van Berge Henegouwen MI, et al
    Reporting National Outcomes After Esophagectomy and Gastrectomy According to the Esophageal Complications Consensus Group (ECCG).
    Ann Surg. 2020;271:1095-1101.
    PubMed     Abstract available


  49. NISHIKAWA K, Fujita T, Yuda M, Tanaka Y, et al
    Quantitative Assessment of Blood Flow in the Gastric Conduit With Thermal Imaging for Esophageal Reconstruction.
    Ann Surg. 2020;271:1087-1094.
    PubMed     Abstract available


    May 2020
  50. SAEKI H, Jogo T, Kawazoe T, Kamori T, et al
    RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307).
    Ann Surg. 2020 May 29. doi: 10.1097/SLA.0000000000003975.
    PubMed     Abstract available


  51. KAMARAJAH SK, Phillips AW, Hanna GB, Low D, et al
    Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-Based Cohort Study.
    Ann Surg. 2020 May 19. doi: 10.1097/SLA.0000000000003941.
    PubMed     Abstract available


    April 2020
  52. WHITE C, Weinstein MC, Fingeret AL, Randolph GW, et al
    Is Less More? A Microsimulation Model Comparing Cost-effectiveness of the Revised American Thyroid Association's 2015 to 2009 Guidelines for the Management of Patients With Thyroid Nodules and Differentiated Thyroid Cancer.
    Ann Surg. 2020;271:765-773.
    PubMed     Abstract available


  53. SCHWAMEIS K, Zehetner J, Green KM, DeMeester SR, et al
    Workload, Recurrence, Quality of Life and Long-term Efficacy of Endoscopic Therapy for High-grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
    Ann Surg. 2020;271:701-708.
    PubMed     Abstract available


    March 2020
  54. VAN DER WILK BJ, van Lanschot JJB
    Response to the Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003861.
    PubMed    


  55. MOLENA D, Louie BE, Demeester SR
    Comment on: "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2020 Mar 6. doi: 10.1097/SLA.0000000000003858.
    PubMed    


  56. CLARK OH
    Thyroid Nodule Guidelines.
    Ann Surg. 2020;271:411.
    PubMed    


    January 2020
  57. YONEKURA H, Nakamori Y, Takeda C, Kawasaki Y, et al
    Comment on "The Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2020 Jan 14. doi: 10.1097/SLA.0000000000003783.
    PubMed    


  58. SAKAMOTO T, Fujiogi M, Yasunaga H
    Response to "Comment On the Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2020 Jan 14. doi: 10.1097/SLA.0000000000003782.
    PubMed    


  59. BERKELMANS GHK, Fransen LFC, Dolmans-Zwartjes ACP, Kouwenhoven EA, et al
    Direct Oral Feeding Following Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial.
    Ann Surg. 2020;271:41-47.
    PubMed     Abstract available


  60. VAN WORKUM F, Slaman AE, van Berge Henegouwen MI, Gisbertz SS, et al
    Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy.
    Ann Surg. 2020;271:128-133.
    PubMed     Abstract available


    December 2019
  61. VAN DER WERF LR, Wijnhoven BPL
    Comment on "Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis".
    Ann Surg. 2019;270:e114.
    PubMed    


  62. YOSHIDA N, Yamamoto H, Miyata H, Baba H, et al
    Response to Comment on "Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database".
    Ann Surg. 2019;270:e110-e111.
    PubMed    


  63. MORIS D, Speicher PJ, D'Amico TA
    Comment on "Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database".
    Ann Surg. 2019;270:e110.
    PubMed    


  64. OKADOME K, Baba Y, Baba H
    Response to Comment on "Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients With Esophageal Cancer".
    Ann Surg. 2019;270:e105-e106.
    PubMed    


  65. OKUGAWA Y, Toiyama Y, Ohi M, Kusunoki M, et al
    Comment on "Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients With Esophageal Cancer".
    Ann Surg. 2019;270:e104-e105.
    PubMed    


    November 2019
  66. VAN DER WERF LR, Wijnhoven BPL, Fransen LFC, van Sandick JW, et al
    A National Cohort Study Evaluating the Association Between Short-term Outcomes and Long-term Survival After Esophageal and Gastric Cancer Surgery.
    Ann Surg. 2019;270:868-876.
    PubMed     Abstract available


  67. SCHRODER W, Raptis DA, Schmidt HM, Gisbertz SS, et al
    Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database.
    Ann Surg. 2019;270:820-826.
    PubMed     Abstract available


    October 2019
  68. VAN DER WILK BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, et al
    Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
    Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636.
    PubMed     Abstract available


    August 2019
  69. MARIETTE C, Markar S, Dabakuyo-Yonli TS, Meunier B, et al
    Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial.
    Ann Surg. 2019 Aug 9. doi: 10.1097/SLA.0000000000003559.
    PubMed     Abstract available


  70. GUTSCHOW CA
    Response to Comment on "Letter to editor: 'Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low-risk Patients"'.
    Ann Surg. 2019;270:e26-e27.
    PubMed    


  71. HELMINEN O, Mrena J, Sihvo E
    Comment on "Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low-risk Patients".
    Ann Surg. 2019;270:e26.
    PubMed    


    July 2019
  72. SAKAMOTO T, Fujiogi M, Matsui H, Fushimi K, et al
    Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis.
    Ann Surg. 2019 Jul 25. doi: 10.1097/SLA.0000000000003500.
    PubMed     Abstract available


  73. URAKAWA S, Makino T, Yamasaki M, Tanaka K, et al
    Lymph Node Response to Neoadjuvant Chemotherapy as an Independent Prognostic Factor in Metastatic Esophageal Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003445.
    PubMed     Abstract available


  74. SEMENKOVICH TR, Hudson JL, Subramanian M, Mullady DK, et al
    Trends in Treatment of T1N0 Esophageal Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003466.
    PubMed     Abstract available


  75. SEMENKOVICH TR, Yan Y, Subramanian M, Meyers BF, et al
    A Clinical Nomogram for Predicting Node-positive Disease in Esophageal Cancer.
    Ann Surg. 2019 Jul 3. doi: 10.1097/SLA.0000000000003450.
    PubMed     Abstract available


  76. LI Y, Zheng Y, Qin J, Chen X, et al
    Response to Comment on "Early Feeding After Esophagectomy: Show Must Go On".
    Ann Surg. 2019;270:e8-e10.
    PubMed    


  77. COOLS-LARTIGUE J, Ferri L
    Radiation Is Not a Solution for Suboptimal Surgery. A Response to the Conclusions Drawn From the Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma With or Without Neoadjuvant Chemoradiotherapy Study.
    Ann Surg. 2019;270:e13-e14.
    PubMed    


  78. VAN LANSCHOT JJB, Noordman BJ
    Response to Letter: "Radiation Is Not a Solution for Suboptimal Surgery. A Response to the Conclusions Drawn From the Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma With or Without Neoadjuvant Chemoradiotherapy Study".
    Ann Surg. 2019;270:e14-e15.
    PubMed    


  79. MORIS D, D'Amico TA
    Comment on "Early Feeding After Esophagectomy: Show Must Go On".
    Ann Surg. 2019;270:e8.
    PubMed    


    June 2019
  80. EYCK BM, Onstenk BD, Noordman BJ, Nieboer D, et al
    Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003397.
    PubMed     Abstract available


  81. KONCZALLA L, Ghadban T, Effenberger KE, Wostemeier A, et al
    Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003406.
    PubMed     Abstract available


  82. LIN JX, Li P, Huang CM
    Comment on "Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers".
    Ann Surg. 2019;269:e75.
    PubMed    


  83. KIYOZUMI Y, Baba Y, Okadome K, Yagi T, et al
    IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2019;269:1101-1108.
    PubMed     Abstract available


    April 2019
  84. WEN J, Wang G, Xie X, Lin G, et al
    Prognostic Value of a Four-miRNA Signature in Patients with Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection.
    Ann Surg. 2019 Apr 30. doi: 10.1097/SLA.0000000000003369.
    PubMed     Abstract available


  85. SEESING MFJ, Wijnhoven BPL
    Response to the Comment on "A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands".
    Ann Surg. 2019;269:e56.
    PubMed    


  86. MEUNIER B, Bergeat D
    Comment on "A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands".
    Ann Surg. 2019;269:e55-e56.
    PubMed    


    March 2019
  87. YUDA M, Yamashita K, Okamura A, Hayami M, et al
    Influence of Preoperative Oropharyngeal Microflora on the Occurrence of Postoperative Pneumonia and Survival in Patients Undergoing Esophagectomy for Esophageal Cancer.
    Ann Surg. 2019 Mar 28. doi: 10.1097/SLA.0000000000003287.
    PubMed     Abstract available


  88. KOSUMI K, Baba Y, Okadome K, Yagi T, et al
    Tumor Long-interspersed Nucleotide Element-1 Methylation Level and Immune Response to Esophageal Cancer.
    Ann Surg. 2019 Mar 26. doi: 10.1097/SLA.0000000000003264.
    PubMed     Abstract available


    February 2019
  89. GOTTLIEB-VEDI E, Kauppila JH, Malietzis G, Nilsson M, et al
    Long-term Survival in Esophageal Cancer After Minimally Invasive Compared to Open Esophagectomy: A Systematic Review and Meta-analysis.
    Ann Surg. 2019 Feb 21. doi: 10.1097/SLA.0000000000003252.
    PubMed     Abstract available


  90. LOW DE, Kuppusamy MK, Alderson D, Cecconello I, et al
    Benchmarking Complications Associated with Esophagectomy.
    Ann Surg. 2019;269:291-298.
    PubMed     Abstract available


    January 2019
  91. YOSHIDA N, Yamamoto H, Baba H, Miyata H, et al
    Can Minimally Invasive Esophagectomy Replace Open Esophagectomy for Esophageal Cancer? Latest Analysis of 24,233 Esophagectomies From the Japanese National Clinical Database.
    Ann Surg. 2019 Jan 31. doi: 10.1097/SLA.0000000000003222.
    PubMed     Abstract available


  92. HASHIMOTO T, Makino T, Yamasaki M, Tanaka K, et al
    The Pattern of Residual Tumor After Neoadjuvant Chemotherapy for Locally Advanced Esophageal Cancer and Its Clinical Significance.
    Ann Surg. 2019 Jan 7. doi: 10.1097/SLA.0000000000003129.
    PubMed     Abstract available


  93. VAN WORKUM F, Stenstra MHBC, Berkelmans GHK, Slaman AE, et al
    Learning Curve and Associated Morbidity of Minimally Invasive Esophagectomy: A Retrospective Multicenter Study.
    Ann Surg. 2019;269:88-94.
    PubMed     Abstract available


    October 2018
  94. KAUPPILA JH, Johar A, Lagergren P
    Medical and Surgical Complications and Health-related Quality of Life After Esophageal Cancer Surgery.
    Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003097.
    PubMed     Abstract available


  95. OKADOME K, Baba Y, Yagi T, Kiyozumi Y, et al
    Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer.
    Ann Surg. 2018 Oct 10. doi: 10.1097/SLA.0000000000002985.
    PubMed     Abstract available


  96. VAN DER SLUIS PC, van der Horst S, May AM, Schippers C, et al
    Robot-assisted Minimally Invasive Thoracolaparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy for Resectable Esophageal Cancer: A Randomized Controlled Trial.
    Ann Surg. 2018 Oct 10. doi: 10.1097/SLA.0000000000003031.
    PubMed     Abstract available


    July 2018
  97. MARKAR SR, Arhi C, Leusink A, Vidal-Diez A, et al
    The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
    Ann Surg. 2018 Jul 24. doi: 10.1097/SLA.0000000000002890.
    PubMed     Abstract available


  98. O'NEILL LM, Guinan E, Doyle SL, Bennett AE, et al
    The RESTORE Randomized Controlled Trial: Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric cancer Survivorship.
    Ann Surg. 2018 Jul 12. doi: 10.1097/SLA.0000000000002895.
    PubMed     Abstract available


  99. KAUPPILA JH, Johar A, Lagergren P
    Postoperative Complications and Health-related Quality of Life 10 Years After Esophageal Cancer Surgery.
    Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002972.
    PubMed     Abstract available


  100. YOSHIDA N, Kosumi K, Tokunaga R, Baba Y, et al
    Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study.
    Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002971.
    PubMed     Abstract available


    June 2018
  101. MARKAR SR, Lagergren J
    Response "Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection".
    Ann Surg. 2018 Jun 1. doi: 10.1097/SLA.0000000000002841.
    PubMed    


    May 2018
  102. LU J, Xie JW, Cao LL, Zheng CH, et al
    Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002835.
    PubMed    


  103. LIN JX, Li P, Huang CM
    Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002833.
    PubMed    


  104. VISSER E, Markar SR, Ruurda JP, Hanna GB, et al
    Prognostic Value of Lymph Node Yield on Overall Survival in Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
    Ann Surg. 2018 May 23. doi: 10.1097/SLA.0000000000002824.
    PubMed     Abstract available


  105. MAKINO T, Yamasaki M, Tanaka K, Masuike Y, et al
    Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer.
    Ann Surg. 2018 May 1. doi: 10.1097/SLA.0000000000002808.
    PubMed     Abstract available


    April 2018
  106. STURM EC, Zahnd WE, Mellinger JD, Ganai S, et al
    Survival Implications of Increased Utilization of Local Excision for cT1N0 Esophageal Cancer.
    Ann Surg. 2018 Apr 18. doi: 10.1097/SLA.0000000000002782.
    PubMed     Abstract available


  107. ADAM MA, Thomas S, Youngwirth L, Hyslop T, et al
    Reply to: "Surgeon Volume Threshold for Total Thyroidectomy".
    Ann Surg. 2018;267:e78-e79.
    PubMed    


  108. AVERY KNL, Chalmers KA, Brookes ST, Blencowe NS, et al
    Development of a Core Outcome Set for Clinical Effectiveness Trials in Esophageal Cancer Resection Surgery.
    Ann Surg. 2018;267:700-710.
    PubMed     Abstract available


  109. BROWN CS, Lapin B, Goldstein JL, Linn JG, et al
    Predicting Progression in Barrett's Esophagus: Development and Validation of the Barrett's Esophagus Assessment of Risk Score (BEAR Score).
    Ann Surg. 2018;267:716-720.
    PubMed     Abstract available


    March 2018
  110. KIYOZUMI Y, Baba Y, Okadome K, Yagi T, et al
    IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2018 Mar 27. doi: 10.1097/SLA.0000000000002754.
    PubMed     Abstract available


  111. SUN HB, Li Y, Liu XB, Zhang RX, et al
    Early Oral Feeding Following McKeown Minimally Invasive Esophagectomy: An Open-label, Randomized, Controlled, Noninferiority Trial.
    Ann Surg. 2018;267:435-442.
    PubMed     Abstract available


  112. WORRELL SG, Alicuben ET, Oh DS, Hagen JA, et al
    Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma.
    Ann Surg. 2018;267:484-488.
    PubMed     Abstract available


  113. BABA Y, Yoshida N, Kinoshita K, Iwatsuki M, et al
    Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study.
    Ann Surg. 2018;267:478-483.
    PubMed     Abstract available


    February 2018
  114. LEE SH, Roh JL, Gong G, Cho KJ, et al
    Risk Factors for Recurrence After Treatment of N1b Papillary Thyroid Carcinoma.
    Ann Surg. 2018 Feb 16. doi: 10.1097/SLA.0000000000002710.
    PubMed     Abstract available


  115. LOWENFELS AB, Maisonneuve P
    Esophageal Cancer: Long-term Survival and Day of Surgery.
    Ann Surg. 2018;267:e26.
    PubMed    


  116. LAGERGREN J, Mattsson F, Lagergren P
    Reply to Letter: "Esophageal Cancer: Long-term Survival and Day of Surgery".
    Ann Surg. 2018;267:e26-e27.
    PubMed    


  117. VAN PUTTEN M, Koeter M, van Laarhoven HWM, Lemmens VEPP, et al
    Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.
    Ann Surg. 2018;267:303-310.
    PubMed     Abstract available


    January 2018
  118. XI M, Yang Y, Zhang L, Yang H, et al
    Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.
    Ann Surg. 2018 Jan 12. doi: 10.1097/SLA.0000000000002670.
    PubMed     Abstract available


  119. PHILLIPS AW, Dent B, Navidi M, Immanuel A, et al
    Trainee Involvement in Ivor Lewis Esophagectomy Does Not Negatively Impact Outcomes.
    Ann Surg. 2018;267:94-98.
    PubMed     Abstract available


    December 2017
  120. SONOHARA F, Gao F, Iwata N, Kanda M, et al
    Genome-wide Discovery of a Novel Gene-expression Signature for the Identification of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2017 Dec 12. doi: 10.1097/SLA.0000000000002622.
    PubMed     Abstract available


  121. YAGI T, Baba Y, Ishimoto T, Iwatsuki M, et al
    PD-L1 Expression, Tumor-infiltrating Lymphocytes, and Clinical Outcome in Patients With Surgically Resected Esophageal Cancer.
    Ann Surg. 2017 Dec 4. doi: 10.1097/SLA.0000000000002616.
    PubMed     Abstract available


  122. ROBB WB, Maillard E, Mariette C
    Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy.
    Ann Surg. 2017;266:e53-e54.
    PubMed    


  123. TALSMA K, Wijnhoven B, van Lanschot J, van Berge Henegouwen M, et al
    Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer: Post hoc Analysis of a Randomized Controlled Trial.
    Ann Surg. 2017;266:e52-e53.
    PubMed    


  124. ZHANG YQ, Chen T, Zhang C, Li QL, et al
    Endoscopic Submucosal Dissection for Superficial Proximal Esophageal Neoplasia is Highly Successful.
    Ann Surg. 2017;266:995-999.
    PubMed     Abstract available


  125. HOANG D, Broer N, Sosa JA, Abitbol N, et al
    Leptin Is Produced by Parathyroid Glands and Stimulates Parathyroid Hormone Secretion.
    Ann Surg. 2017;266:1075-1083.
    PubMed     Abstract available


  126. SCHNEIDER A, Michaud L, Gottrand F
    Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.
    Ann Surg. 2017;266:e96.
    PubMed    


  127. VERGOUWE FWT, Wijnen RMH, Bruno MJ, Spaander MCW, et al
    Prevalence of Barrett Esophagus in Adolescents and Young Adults With Esophageal Atresia.
    Ann Surg. 2017;266:e95-e96.
    PubMed    


    November 2017
  128. SEESING MFJ, Gisbertz SS, Goense L, van Hillegersberg R, et al
    A Propensity Score Matched Analysis of Open Versus Minimally Invasive Transthoracic Esophagectomy in the Netherlands.
    Ann Surg. 2017;266:839-846.
    PubMed     Abstract available


  129. VISSER E, Rossum PSNV, Ruurda JP, Hillegersberg RV, et al
    Impact of Lymph Node Yield on Overall Survival in Patients Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy for Cancer: A Population-based Cohort Study in the Netherlands.
    Ann Surg. 2017;266:863-869.
    PubMed     Abstract available


    August 2017
  130. ELLIOTT JA, Doyle SL, Murphy CF, King S, et al
    Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Ann Surg. 2017 Aug 8. doi: 10.1097/SLA.0000000000002398.
    PubMed     Abstract available


  131. GRAJEK M, Maciejewski A, Giebel S, Krakowczyk L, et al
    First Complex Allotransplantation of Neck Organs: Larynx, Trachea, Pharynx, Esophagus, Thyroid, Parathyroid Glands, and Anterior Cervical Wall: A Case Report.
    Ann Surg. 2017;266:e19-e24.
    PubMed     Abstract available


  132. STRAATMAN J, van der Wielen N, Cuesta MA, Daams F, et al
    Minimally Invasive Versus Open Esophageal Resection: Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial.
    Ann Surg. 2017;266:232-236.
    PubMed     Abstract available


    July 2017
  133. MANTZIARI S, Gronnier C, Renaud F, Duhamel A, et al
    Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002402.
    PubMed     Abstract available


  134. DEGISORS S, Pasquer A, Renaud F, Behal H, et al
    Are Thoracotomy and/or Intrathoracic Anastomosis Still Predictors of Postoperative Mortality After Esophageal Cancer Surgery?: A Nationwide Study.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002401.
    PubMed     Abstract available


  135. STEFFEN T, Dietrich D, Schnider A, Kettelhack C, et al
    Recurrence Patterns and Long-Term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer.
    Ann Surg. 2017 Jul 24. doi: 10.1097/SLA.0000000000002435.
    PubMed     Abstract available


  136. MARKAR SR, Mackenzie H, Askari A, Faiz O, et al
    Effect of Esophageal Cancer Surgeon Volume on Management and Mortality From Emergency Upper Gastrointestinal Conditions: Population-based Cohort Study.
    Ann Surg. 2017 Jul 12. doi: 10.1097/SLA.0000000000002387.
    PubMed     Abstract available


  137. MORIS D, Dimitroulis D
    The Comparison of Surgical Approaches in Locally Advanced Esophageal Cancer: Significant Insights but Clinical Fidelity Still to Be Delivered.
    Ann Surg. 2017;266:e11-e12.
    PubMed    


  138. VISSER E, van Rossum PSN, Verhoeven RHA, Ruurda JP, et al
    Impact of Weekday of Esophagectomy on Short-term and Long-term Oncological Outcomes: A Nationwide Population-based Cohort Study in the Netherlands.
    Ann Surg. 2017;266:76-81.
    PubMed     Abstract available


  139. ZAIDI AH, Kosovec JE, Matsui D, Omstead AN, et al
    PI3K/mTOR Dual Inhibitor, LY3023414, Demonstrates Potent Antitumor Efficacy Against Esophageal Adenocarcinoma in a Rat Model.
    Ann Surg. 2017;266:91-98.
    PubMed     Abstract available


  140. ELLIOTT JA, Docherty NG, Eckhardt HG, Doyle SL, et al
    Weight Loss, Satiety, and the Postprandial Gut Hormone Response After Esophagectomy: A Prospective Study.
    Ann Surg. 2017;266:82-90.
    PubMed     Abstract available


    June 2017
  141. BARBOUR AP, Cormack OMM, Baker PJ, Hirst J, et al
    Long-term Health-related Quality of Life Following Esophagectomy: A Nonrandomized Comparison of Thoracoscopically Assisted and Open Surgery.
    Ann Surg. 2017;265:1158-1165.
    PubMed     Abstract available


  142. WONG AT, Shao M, Rineer J, Lee A, et al
    The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
    Ann Surg. 2017;265:1146-1151.
    PubMed     Abstract available


  143. WILSON MZ, Enomoto LM, Messaris E, Hollenbeak CS, et al
    Misapplication of Statistical Methods May Lead to Misinformation.
    Ann Surg. 2017;265:E78-E79.
    PubMed    


    May 2017
  144. ROBB WB, Mariette C
    Reply to Letter: "Tumor Response and Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2017;265:e69-e70.
    PubMed    


  145. ECKER BL, Dempsey DT
    In Response to "Impact of Neoadjuvant Chemoradiation on Lymph Node Status in Esophageal Cancer".
    Ann Surg. 2017;265:e69.
    PubMed    


    April 2017
  146. LI B, Hu H, Zhang Y, Zhang J, et al
    Extended Right Thoracic Approach Compared With Limited Left Thoracic Approach for Patients With Middle and Lower Esophageal Squamous Cell Carcinoma: Three-year Survival of a Prospective, Randomized, Open-label Trial.
    Ann Surg. 2017 Apr 26. doi: 10.1097/SLA.0000000000002280.
    PubMed     Abstract available


  147. NAKASHIMA Y, Saeki H, Nakanishi R, Sugiyama M, et al
    Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.
    Ann Surg. 2017 Apr 21. doi: 10.1097/SLA.0000000000002252.
    PubMed     Abstract available


  148. MARKAR SR, Mackenzie H, Lagergren P, Lagergren J, et al
    Surgeon Age in Relation to Prognosis After Esophageal Cancer Resection.
    Ann Surg. 2017 Apr 7. doi: 10.1097/SLA.0000000000002260.
    PubMed     Abstract available


  149. PHILLIPS AW, Lagarde SM, Navidi M, Disep B, et al
    Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy.
    Ann Surg. 2017;265:750-756.
    PubMed     Abstract available


  150. BANSAL N, Mayilvaganan S
    Primary Hyperparathyroidism With Negative Imaging: A Significant Clinical Problem.
    Ann Surg. 2017;265:e41.
    PubMed    


    March 2017
  151. MARKAR SR, Mackenzie H, Jemal S, Faiz O, et al
    Emergency Presentation of Esophagogastric Cancer: Predictors and Long-term Prognosis.
    Ann Surg. 2017 Mar 20. doi: 10.1097/SLA.0000000000002224.
    PubMed     Abstract available


  152. PASQUALI S, Yim G, Vohra RS, Mocellin S, et al
    Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis.
    Ann Surg. 2017;265:481-491.
    PubMed     Abstract available


    February 2017
  153. CHEN T, Zhou PH, Chu Y, Zhang YQ, et al
    Long-term Outcomes of Submucosal Tunneling Endoscopic Resection for Upper Gastrointestinal Submucosal Tumors.
    Ann Surg. 2017;265:363-369.
    PubMed     Abstract available


  154. SHAPIRO J, Biermann K, van Klaveren D, Offerhaus GJ, et al
    Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer.
    Ann Surg. 2017;265:356-362.
    PubMed     Abstract available


  155. VAN OLPHEN SH, Biermann K, Shapiro J, Wijnhoven BP, et al
    P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
    Ann Surg. 2017;265:347-355.
    PubMed     Abstract available


    July 2016
  156. PASQUER A, Renaud F, Hec F, Gandon A, et al
    Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study.
    Ann Surg. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: